Lucie Ellis

Top 30 leaders: see the list of industry influencers highlighted in the fourth edition of In Vivo's Rising Leaders series. https://t.co/9S81KiLcG7

#LSXworld "We are excited about platforms... @novonordisk is most interested in gene editing deals." Comments from John McDonald.

Interesting chat at #LSXworld this morning. @novonordisk's John McDonald says the company will no longer be a "window shopper". Looking to partner earlier to grow pipeline but staying well away from oncology.

RT @PharmaScrip: Trial Hot Spot: Australia's Attractions To The Korean Industry https://t.co/MDJqtU1xak #PharmaScrip

RT @INVIVOnow: Europe’s Big Pharma Players Begin Tricky 2022 In Style https://t.co/P2LcxG5LbN

RT @INVIVOnow: China Takes A Bigger Role In The World Pharma Stage https://t.co/Ywhl7jIrby

RT @INVIVOnow: Elizabeth Jungman: Interpreter Of The FDA’s Policy Crystal Ball https://t.co/CQ7DgzQNX1

After years of the front runners struggling to overcome problems with allogeneic or ‘off-the-shelf’ CAR-T therapies, Caribou Biosciences has unveiled early data which suggest it may just have cracked the challenge with its candidate CB-010. https://t.co/VNtFs0zA3i

Roche has suffered a major setback in its goal to lead in a new class of cancer immunotherapies, with the surprise failure of its anti-TIGIT tiragolumab in non-small cell lung cancer. https://t.co/wSsly3oNWH

RT @bradloncar: Roche TIGIT SKYSCRAPER-01 failed (on PFS). Ugh

RT @dgingery: (1/2) Here's two stories looking at recent filings and approval #pinksheet #pharma: Story 1 is the nearly weekly keeping trac…

RT @dgingery: (2/2) Story 2 is a look at breakthrough designations ... #pinksheet #pharma: https://t.co/dkxuES4W4T

RT @INVIVOnow: 2021 Global Biopharma R&D Productivity And Growth Ranking https://t.co/KRRu9LSSTB

Biotech firm @omasstx today completed an impressive $100m series B round. CEO Ros Deegan, one of In Vivo’s 2022 rising leaders, believes the firm’s proprietary technology platform could open the door to an innovative approach to drug discovery. https://t.co/i3sqx6MfZU

RT @ByMadeleineA: Bernstein's Ronny Gal is joining $NVS as chief strategy & growth officer from August. Big move!

RT @PharmaScrip: Another Blow To Aduhelm As Biogen Withdraws EU Filing https://t.co/1Q3ROkO815 #PharmaScrip

RT @WalbrookPR: 3rd annual listing of @INVIVOnow ‘Rising Leaders’ 📰 🏅 @TrellusHealth Co-Founder Laurie Keefer nominated by @LucieLEllis as…